Cargando…

Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint Inhibition

PURPOSE: Prior studies have mixed conclusions about the efficacy and central nervous system (CNS) toxicity profile of combining radiosurgery with anti-programed cell death 1 (PD-1) immune checkpoint inhibition (ICI) for brain metastases. This study evaluates the safety and efficacy of combined radio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Travis, Roman L., Marcrom, Samuel R., Brown, Matthew H., Patel, Mayank P., Markert, James M., Riley, Kristen O., Conry, Robert, Willey, Christopher D., Bredel, Markus, Fiveash, John B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897762/ https://www.ncbi.nlm.nih.gov/pubmed/33665483 http://dx.doi.org/10.1016/j.adro.2020.08.017

Ejemplares similares

RADI-18. STEREOTACTIC RADIOSURGERY OR FRACTIONATED STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM SMALL CELL LUNG CANCER
por: Thomas, Evan, et al.
Publicado: (2019)

RADI-12. LEPTOMENINGEAL FAILURE AFTER PREOPERATIVE VERSUS POSTOPERATIVE RADIOSURGERY
por: Fiveash, John, et al.
Publicado: (2019)

Surface guided imaging during stereotactic radiosurgery with automated delivery
por: Covington, Elizabeth L., et al.
Publicado: (2020)

Fractionated stereotactic radiation therapy for intact brain metastases
por: Marcrom, Samuel R., et al.
Publicado: (2017)

Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease
por: Marcrom, Samuel R., et al.
Publicado: (2019)

A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases
por: Fiveash, John B., et al.
Publicado: (2016)

Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis
por: Bodensohn, Raphael, et al.
Publicado: (2023)

Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases
por: Bander, Evan D., et al.
Publicado: (2023)

Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017)

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study
por: Amaral, Teresa, et al.
Publicado: (2020)

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
por: Trommer-Nestler, Maike, et al.
Publicado: (2018)

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases
por: Lehrer, Eric J., et al.
Publicado: (2018)

Stereotactic radiosurgery for brain metastases from malignant melanoma
por: Christ, Sebastian M., et al.
Publicado: (2015)

Stereotactic radiosurgery with MLC‐defined arcs: Verification of dosimetry, spatial accuracy, and end‐to‐end tests
por: Brezovich, Ivan A., et al.
Publicado: (2019)

Stereotactic radiosurgery for ruptured versus unruptured intracranial arteriovenous malformations
por: Mooney, James, et al.
Publicado: (2022)

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
por: Minniti, Giuseppe, et al.
Publicado: (2019)

Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies
por: Zoga, Eleni, et al.
Publicado: (2022)

Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes
por: Shanker, Mihir D, et al.
Publicado: (2022)

Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases
por: Wong, Philip, et al.
Publicado: (2023)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
por: Reynolds, Margaret M., et al.
Publicado: (2017)

Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis
por: Prabhu, Roshan S., et al.
Publicado: (2021)

Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases
por: Starck, Lea, et al.
Publicado: (2022)

Collagen deposition within brain metastases is associated with leptomeningeal failure after  cavity-directed radiosurgery
por: Abdulhaleem, Mohammed, et al.
Publicado: (2023)

Commissioning and clinical evaluation of the IDENTIFY(TM) surface imaging system for frameless stereotactic radiosurgery
por: Covington, Elizabeth L., et al.
Publicado: (2023)

Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy
por: Burke, Aidan M., et al.
Publicado: (2022)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
por: LWU, SHELLY, et al.
Publicado: (2013)

Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
por: Liermann, Jakob, et al.
Publicado: (2020)

Feasibility and safety of cavity-directed stereotactic radiosurgery for brain metastases at a high-volume medical center
por: Rava, Paul, et al.
Publicado: (2016)

Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies
por: Shen, Hongxing, et al.
Publicado: (2019)

Treatment of patients with multiple brain metastases by isolated radiosurgery: Toxicity and survival
por: de Camargo, André Vinícius, et al.
Publicado: (2023)

Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti–PD-1 Era
por: Lamba, Nayan, et al.
Publicado: (2022)

A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain
por: Ruzevick, Jacob, et al.
Publicado: (2013)

Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review
por: Weaver, Bradley D, et al.
Publicado: (2019)

A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria
por: Skeie, Bente Sandvei, et al.
Publicado: (2020)

Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases
por: Carpenter, David J., et al.
Publicado: (2023)

Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA
por: Kessel, K. A., et al.
Publicado: (2021)

31. RADIATION NECROSIS IN STEREOTACTIC RADIOSURGERY AND CHECKPOINTS INHIBITORS FOR BRAIN METASTASES FROM LUNG ADENOCARCINOMA
por: Jurica, James, et al.
Publicado: (2020)

Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery
por: Teyateeti, Achiraya, et al.
Publicado: (2021)

Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy—A retrospective cohort study
por: Gatterbauer, Brigitte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_alsfverd8sq4t5b10gfv2pftol